Company intelligence / Profile preview
Applied Therapeutics, Inc.
New York, New York, United Statesappliedtherapeutics.gcs-web.com ↗
- Ownership
- Public · APLT
- Employees
- ~35
- Development stage
- NDA
01
Overview
Applied Therapeutics has completed Phase 3 trials for govorestat (AT-007) in galactosemia and received a Complete Response Letter from the FDA in November 2024. The company reported positive 12-month interim results from the Phase 3 INSPIRE trial for SORD Deficiency in February 2024, with primary endpoints and several key secondary endpoints achieved. Their AT-001 compound for Diabetic Cardiomyopathy has completed Phase 3 trials.
- Therapeutic areas
- CardiovascularMetabolic DisordersOphthalmologyEndocrinologyRare DiseasesNeurology
- Modalities
- Small molecules (Aldose Reductase Inhibitors)
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
Advanz Pharma (commercialization of AT-007/govorestat in Europe)Mercury Pharma Group Limited (exclusive license and supply agreement for drug products containing AT-007)
04
Financials
- Market cap
- $14.9M
- Total revenue
- $1M
- Enterprise value
- $5.4M
Beyond the preview
Go deeper on Applied Therapeutics, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Applied Therapeutics, Inc..